Literature DB >> 15698972

Managing drugs safely.

John N van den Anker1.   

Abstract

There is hard data to show that newborn infants are more likely than adults to experience adverse reactions to drugs. Paradoxically, drug-related legislation to ensure safe and effective drug use in humans neglected neonates until 2002, when the Best Pharmaceuticals Act for Children was signed into law in the USA. The situation for neonates should now catch up with that for adults and neonates will be prescribed more licensed drugs in the near future. If we are to be able to analyze the underlying system errors to improve the safe use of drugs in the studied patient population, reporting of adverse drug events and reactions needs to happen in a blame free environment. In addition, computerized physician order entry will certainly further improve the current situation by preventing errors in ordering, transcribing, verifying, and transmitting medication orders.

Entities:  

Mesh:

Year:  2005        PMID: 15698972     DOI: 10.1016/j.siny.2004.09.005

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  9 in total

1.  Opioid medication errors in pediatric practice: four years' experience of voluntary safety reporting.

Authors:  Conor Mc Donnell
Journal:  Pain Res Manag       Date:  2011 Mar-Apr       Impact factor: 3.037

2.  Data analysis of the benefits of an electronic registry of information in a neonatal intensive care unit in Greece.

Authors:  Maria Skouroliakou; George Soloupis; Antonis Gounaris; Antonia Charitou; Petros Papasarantopoulos; Sophia L Markantonis; Christina Golna; Kyriakos Souliotis
Journal:  Perspect Health Inf Manag       Date:  2008-07-28

3.  Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2012-08-08

4.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

5.  Neonates need tailored drug formulations.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2013-02-08

Review 6.  Incidents and errors in neonatal intensive care: a review of the literature.

Authors:  C Snijders; R A van Lingen; A Molendijk; W P F Fetter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03-21       Impact factor: 5.747

7.  Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.

Authors:  S Suna Oguz; H Gozde Kanmaz; Ugur Dilmen
Journal:  Int J Clin Pharm       Date:  2012-01-11

Review 8.  Safety of sildenafil in infants*.

Authors:  Samira Samiee-Zafarghandy; P Brian Smith; Johannes N van den Anker
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624

9.  Medication safety in neonatal care: a review of medication errors among neonates.

Authors:  Natalia Krzyzaniak; Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2016-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.